Sage Still Sees Approval Path After Depression Drug Fails In Phase III Trial

 
• By Leah Samuel
Sunrise in Snowy Mountains
The Phase III MOUNTAIN trial missed the primary endpoint

More from Clinical Trials

More from R&D